Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Semin Liver Dis
    June 2022
  1. GARCIA-SAENZ-DE-SICILIA M, Al-Obaid L, Hughes DL, Duarte-Rojo A, et al
    Mastering core recommendations during HEPAtology ROUNDS in advanced chronic liver disease.
    Semin Liver Dis. 2022 Jun 28. doi: 10.1055/a-1886-5909.
    >> Share

  2. CHEW N, Ng CH, Truong E, Noureddin M, et al
    Non-Alcoholic Steatohepatitis Drug Development Pipeline: An Update.
    Semin Liver Dis. 2022 Jun 16. doi: 10.1055/a-1877-9656.
    >> Share

  3. KULKARNI AV, Premkumar M, Arab JP, Kumar K, et al
    EARLY DIAGNOSIS AND PREVENTION OF INFECTIONS IN CIRRHOSIS.
    Semin Liver Dis. 2022 Jun 7. doi: 10.1055/a-1869-7607.
    >> Share

    May 2022
  4. GRINSPAN LT, Villanueva A
    Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma.
    Semin Liver Dis. 2022;42:188-201.
    >> Share

  5. YUAN WZ, Fu T
    Liver Dysfunction in COVID-19: From Onset to Recovery.
    Semin Liver Dis. 2022;42:151-158.
    >> Share

  6. GUPTA B, Rai R, Oertel M, Raeman R, et al
    Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids.
    Semin Liver Dis. 2022;42:122-137.
    >> Share

  7. TARLI C, Mirijello A, Addolorato G
    Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.
    Semin Liver Dis. 2022;42:138-150.
    >> Share

  8. FASULLO M, Shah T, Zhou H, Siddiqui MS, et al
    Post-Transplant Biliary Strictures: An Updated Review.
    Semin Liver Dis. 2022;42:225-232.
    >> Share

  9. CARROLL HK, Duffy AG, O'Farrelly C
    Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?
    Semin Liver Dis. 2022;42:212-224.
    >> Share

    February 2022
  10. GALLAHER CE, Shawcross DL
    Management of multidrug-resistant infections in cirrhosis.
    Semin Liver Dis. 2022 Feb 7. doi: 10.1055/a-1765-0056.
    >> Share

  11. PANDAY R, Monckton CP, Khetani SR
    The Role of Liver Zonation in Physiology, Regeneration, and Disease.
    Semin Liver Dis. 2022;42:1-16.
    >> Share

  12. CADAMURO M, Lasagni A, Sarcognato S, Guido M, et al
    The Neglected Role of Bile Duct Epithelial Cells in NASH.
    Semin Liver Dis. 2022;42:34-47.
    >> Share

  13. TERZI E, Ayuso C, Piscaglia F, Bruix J, et al
    Liver Imaging Reporting and Data System: Review of Pros and Cons.
    Semin Liver Dis. 2022;42:104-111.
    >> Share

    November 2021
  14. TELLEZ L, Rodriguez de Santiago E, Albillos A
    Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management.
    Semin Liver Dis. 2021;41:538-550.
    >> Share

  15. RADUN R, Trauner M
    Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
    Semin Liver Dis. 2021;41:461-475.
    >> Share

  16. MAIWALL R, Sarin SK
    Plasma Exchange in Acute and Acute on Chronic Liver Failure.
    Semin Liver Dis. 2021;41:476-494.
    >> Share

  17. GU X, Lu Q, Zhang C, Tang Z, et al
    Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review.
    Semin Liver Dis. 2021;41:495-506.
    >> Share

  18. MENDOZA YP, Becchetti C, Watt KD, Berzigotti A, et al
    Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:448-460.
    >> Share

  19. HASHEM A, Khalouf A, Acosta A
    Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review.
    Semin Liver Dis. 2021;41:435-447.
    >> Share

  20. ARRESE M, Arab JP, Barrera F, Kaufmann B, et al
    Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity.
    Semin Liver Dis. 2021;41:421-434.
    >> Share

  21. KOHUT TJ, Gilbert MA, Loomes KM
    Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
    Semin Liver Dis. 2021;41:525-537.
    >> Share

  22. LI N, Yamamoto G, Fuji H, Kisseleva T, et al
    Interleukin-17 in Liver Disease Pathogenesis.
    Semin Liver Dis. 2021;41:507-515.
    >> Share

    October 2021
  23. JENG WJ, Liaw YF
    Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Oct 1. doi: 10.1055/s-0041-1737024.
    >> Share

    September 2021
  24. MARIN JJG, Romero MR, Herraez E, Asensio M, et al
    Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems.
    Semin Liver Dis. 2021 Sep 20. doi: 10.1055/s-0041-1735631.
    >> Share

    August 2021
  25. SHERMAN M
    Assessing Toxicity in Drug Trials in Liver Disease.
    Semin Liver Dis. 2021;41:277-284.
    >> Share

  26. KAWAGUCHI T, Charlton M, Kawaguchi A, Yamamura S, et al
    Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
    Semin Liver Dis. 2021;41:225-234.
    >> Share

  27. ZELBER-SAGI S
    Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations.
    Semin Liver Dis. 2021;41:248-262.
    >> Share

  28. NILLES KM, Levitsky J
    Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.
    Semin Liver Dis. 2021;41:308-320.
    >> Share

  29. MA L, Khatib S, Craig AJ, Wang XW, et al
    Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution.
    Semin Liver Dis. 2021;41:321-330.
    >> Share

  30. MOLLER S, Kimer N, Kronborg T, Grandt J, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.
    Semin Liver Dis. 2021;41:235-247.
    >> Share

  31. ENGELMANN C, Martino VD, Kerbert AJC, Weil-Verhoeven D, et al
    The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2021;41:298-307.
    >> Share

    July 2021
  32. VAZ K, Goodwin T, Kemp W, Roberts S, et al
    Artificial Intelligence in Hepatology: A Narrative Review.
    Semin Liver Dis. 2021 Jul 29. doi: 10.1055/s-0041-1731706.
    >> Share

  33. ZHOU Y, Tao J, Calvisi DF, Chen X, et al
    Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jul 26. doi: 10.1055/s-0041-1731709.
    >> Share

  34. KAHL S, Putzer J, Roden M
    Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2021 Jul 21. doi: 10.1055/s-0041-1732354.
    >> Share

    June 2021
  35. JENG WJ, Liaw YF
    Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Jun 28. doi: 10.1055/s-0041-1729973.
    >> Share

  36. HSU YC, Tseng CH, Huang YT, Yang HI, et al
    Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730924.
    >> Share

  37. BRESSON-HADNI S, Spahr L, Chappuis F
    Hepatic Alveolar Echinococcosis.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730925.
    >> Share

  38. SU YY, Li CC, Lin YJ, Hsu C, et al
    Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives.
    Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730949.
    >> Share

    May 2021
  39. HAEP N, Florentino RM, Squires JE, Bell A, et al
    The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone.
    Semin Liver Dis. 2021 May 15. doi: 10.1055/s-0041-1725023.
    >> Share

  40. USON JUNIOR PLS, Nagalo BM, Ahn DH, Bekaii-Saab T, et al
    Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0040-1722646.
    >> Share

  41. MOECKLI B, Majno P, Orci LA, Peloso A, et al
    Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723032.
    >> Share

  42. SEKIBA K, Otsuka M, Koike K
    Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723033.
    >> Share

  43. GIL-GOMEZ A, Brescia P, Rescigno M, Romero-Gomez M, et al
    Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers.
    Semin Liver Dis. 2021;41:191-205.
    >> Share

  44. ORTIZ V, Ellenberg SS, Weinberg EM
    Blinding in Clinical Trials for Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:163-171.
    >> Share

  45. DUNN MA, Kappus MR, Bloomer PM, Duarte-Rojo A, et al
    Wearables, Physical Activity, and Exercise Testing in Liver Disease.
    Semin Liver Dis. 2021;41:128-135.
    >> Share

    January 2021
  46. YAO FY, Fidelman N, Mehta N
    The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jan 14. doi: 10.1055/s-0040-1716565.
    >> Share

  47. ROEDIGER R, Fleckenstein J
    Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management.
    Semin Liver Dis. 2021;41:103-108.
    >> Share

  48. STOTTS MJ, Wentworth BJ, Northup PG
    Management of Portal Vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2021;41:79-86.
    >> Share

  49. WILKINSON PD, Duncan AW
    Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury.
    Semin Liver Dis. 2021;41:42-49.
    >> Share

  50. ZHANG Y, Solinas A, Cairo S, Evert M, et al
    Molecular Mechanisms of Hepatoblastoma.
    Semin Liver Dis. 2021;41:28-41.
    >> Share

  51. DHANASEKARAN R
    Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.
    Semin Liver Dis. 2021;41:9-18.
    >> Share

  52. BYRD K, Alqahtani S, Yopp AC, Singal AG, et al
    Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma.
    Semin Liver Dis. 2021;41:1-8.
    >> Share

  53. HARTMANN P, Schnabl B
    New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2021;41:87-102.
    >> Share

  54. FERREIRA-GONZALEZ S, Rodrigo-Torres D, Gadd VL, Forbes SJ, et al
    Cellular Senescence in Liver Disease and Regeneration.
    Semin Liver Dis. 2021;41:50-66.
    >> Share

  55. WANG H, Calvisi DF, Chen X
    Organoids for the Study of Liver Cancer.
    Semin Liver Dis. 2021;41:19-27.
    >> Share

    September 2020
  56. HEIMBACH JK
    Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma.
    Semin Liver Dis. 2020 Sep 17. doi: 10.1055/s-0040-1709492.
    >> Share

  57. ROWE IA
    Histological Endpoints for Nonalcoholic Steatohepatitis Trials: Lights and Shadows.
    Semin Liver Dis. 2020 Sep 9. doi: 10.1055/s-0040-1709491.
    >> Share

    August 2020
  58. LIZARDO-THIEBAUD MJ, Cervantes-Alvarez E, Limon-de la Rosa N, Tejeda-Dominguez F, et al
    Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Semin Liver Dis. 2020;40:321-330.
    >> Share

    June 2020
  59. MANDORFER M, Hernandez-Gea V, Garcia-Pagan JC, Reiberger T, et al
    Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review.
    Semin Liver Dis. 2020 Jun 18. doi: 10.1055/s-0040-1708806.
    >> Share

  60. KNORR J, Wree A, Tacke F, Feldstein AE, et al
    The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1708540.
    >> Share

  61. IBRAHIM SH, Hirsova P, Malhi H, Gores GJ, et al
    Nonalcoholic Steatohepatitis Promoting Kinases.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1713115.
    >> Share

  62. FREEBURG SH, Goessling W
    Hepatobiliary Differentiation: Principles from Embryonic Liver Development.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1709679.
    >> Share

    May 2020
  63. SUGAHARA G, Ishida Y, Sun J, Tateno C, et al
    Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice.
    Semin Liver Dis. 2020;40:189-212.
    >> Share

  64. ABERG F, Farkkila M
    Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.
    Semin Liver Dis. 2020;40:154-162.
    >> Share

  65. DOLIN CE, Arteel GE
    The Matrisome, Inflammation, and Liver Disease.
    Semin Liver Dis. 2020;40:180-188.
    >> Share

  66. JORDAN RI, Tandon P
    Emerging Role of Palliative Care in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2020;40:163-170.
    >> Share

  67. HILSCHER MB, Shah VH
    Neutrophil Extracellular Traps and Liver Disease.
    Semin Liver Dis. 2020;40:171-179.
    >> Share

    April 2020
  68. MATSUDA M, Seki E
    Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
    Semin Liver Dis. 2020 Apr 2. doi: 10.1055/s-0040-1708876.
    >> Share

    February 2020
  69. KANG N
    Mechanotransduction in Liver Diseases.
    Semin Liver Dis. 2020;40:84-90.
    >> Share

  70. FICKERT P, Rosenkranz AR
    Cholemic Nephropathy Reloaded.
    Semin Liver Dis. 2020;40:91-100.
    >> Share

  71. LLEO A, Leung PSC, Hirschfield GM, Gershwin EM, et al
    The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.
    Semin Liver Dis. 2020;40:34-48.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016